Poland· PL-100351080
Bendamustine Zentiva
A bendamustine product containing bendamustini hydrochloridum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bendamustine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AA09 (bendamustine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Bendamustine · ATC L01AA09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bendamustine costs, country by country.
Normalised to the WHO defined daily dose (17 mg), the median price runs from $1.82 in Czechia to $45.03 in Switzerland — a ×25 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bendamustine · price per daily dose (17 mg)
USD · FX 28 Sept 2026
- CH Switzerland$45.03
- CZ Czechia$1.82
The record
At a glance
URPL (Poland)- Active substance
- Bendamustini hydrochloridum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- L01AA09
- ATC class
- Bendamustine
- Defined daily dose
- 17 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991267261
- gtin05909991267278
- gtin05909991267285
- gtin05909991267292
- gtin05909991267308
- gtin05909991267315
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
174 interactions on record for bendamustine.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bendamustine · interactions on record
174 records
- 29 severe
- 145 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bendamustine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBendamustine Accord 2.5 mg/mlAccord Healthcare
- FinlandAlkybendUAB Norameda
- CzechiaBENDAMUSTINE ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SpainBENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- SwedenBendamustin Actavis 2,5 mg/ml Pulver till koncentrat till infusionsvätska, lösningActavis Group PTC ehf.
- IcelandBendamustine AccordAccord Healthcare B.V.
- NorwayBendamustine AccordAccord Healthcare B.V.
- United StatesBELRAPZOEagle Pharmaceuticals, Inc
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bendamustin Accord, Bendamustin Hikma
- Belgium · Bendamustine Accord, Bendamustine Eugia
- Bulgaria · Бендамустин Акорд, Бендамустин Актавис
- Cyprus · Bendamustin Ledpharm, Bendamustine Accord
- Czechia · Bendamustine Accord, Bendamustine Kabi
- Germany · Benda Nc, Bendamustin Accord
- Denmark · Bendamedac, Bendamustin Actavis
- Estonia · Bendamustine Accord, Bendamustine Kabi
- Spain · Bendamustina Accord, Bendamustina Aurovitas
- Finland · Bendamustine Accord, Bendamustine Avansor
- France · Bendamustine Accord, Bendamustine Arrow
- United Kingdom (Northern Ireland) · Bendamustine Hikma Farmacêutica (Portugal), Bendamustine Hydrochloride
- Greece · Bendamustine Accord, Bendamustine Actavis
- Croatia · Bendamustin Kabi, Bendamustin Pharmas
- Hungary · Bendamustin Teva, Bendamustine Accord
- Ireland · Bendamustine Accord Healthcare, Bendamustine Accord Healthcare Ireland
- Iceland · Bendamustine Accord, Bendamustine Medac
- Italy · Bendamustina Accord, Bendamustina Aurobindo
- Lithuania · Bendamustine Accord, Bendamustine Kabi
- Luxembourg · Bendamustine Fresenius Kabi, Levact
- Latvia · Bendamustine Accord, Bendamustine Kabi
- Malta · Bendamustine Accord Healthcare, Bendamustine Hydrochloride
- Netherlands · Bendamustine Accord, Bendamustine Baxter
- Norway · Bendamustine Accord, Bendamustine Fresenius Kabi
- Portugal · Bendamustina Accord, Bendamustina Generis
- Romania · Bendamustina Accord, Bendamustină Accord
- Sweden · Bendamustin Actavis, Bendamustine Accord
- Slovenia · Bendamustin Accord, Bendamustin Kabi
- Slovakia · Bendamustine Accord, Bendamustine Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1d96451-f55b-45c6-8ab3-a560f54b63ff GET /v1/drugs/e1d96451-f55b-45c6-8ab3-a560f54b63ff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "2,5 mg/ml",
"packaging": "05909991267261 ¦ Rp ¦ 114755\n1 fiol. 25 mg\n05909991267278 ¦ Rp ¦ 114756\n1 fiol. 100 mg\n05909991267285 ¦ Rp ¦ 114757\n5 fiol. 100 mg\n05909991267292 ¦ Rp ¦ 114758\n5 fiol. 25 mg\n05909991267308 ¦ Rp ¦ 114759\n10 fiol. 25 mg\n05909991267315 ¦ Rp ¦ 114760\n20 fiol. 25 mg",
"substance": "Bendamustini hydrochloridum monohydricum (monohydricum) 26.1 mg/fiolkę lub 104.6 mg/fiolkę",
"common_name": "Bendamustini hydrochloridum",
"pl_product_id": "100351080",
"pozwolenie_nr": "23050",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about bendamustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.